Drug maker Gilead Sciences said that within 11 days, 134 of the 191 patients given a five-course of remdesivir showed at least two points of improvement on the tracking scale, and no one died. That data showed the drug shortened the course of illness from an average of 15 days to about 11. This is an absolutely awesome sign!!!
Photo Credit: MARK ADRIANE